Why Medibank and NIB shares might be in the buy zone

Are ASX private health shares Medibank Private Ltd (ASX: MPL) and NIB Holdings Ltd (ASX: NHF) in the buy zone today?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are ASX private health insurers Medibank Private Ltd (ASX: MPL) and NIB Holdings Limited (ASX: NHF) shares in the buy zone today?

A lot of negative coverage of the private health insurance business has been dominating the news lately.

Take this report from ABC – which declares the private health business model to be in a 'death spiral' from increasing costs and more and more people abandoning coverage (especially the young). According to the report, just 44% of Australians now have basic hospital cover.

a woman

How does private health insurance work?

Like any insurance, private health works by collecting premiums from all customers and paying out those who make legitimate claims. The more people in the fund, the less the average premium should be (in theory at least).

The problem for private health insurers like Medibank Private and NIB is that this particular industry is heavily regulated by the government. Sure, on one hand, there are tax incentives such as the Medicare Levy Surcharge and Private Health Insurance Rebate that work to encourage customers to take out private health insurance.

But on the other, there are rules that limit these companies to how much they can raise their premiums every year as well as how much they are allowed to charge their customers (for example, older members as opposed to younger members).

I'm not disputing the social merits of these policies here, but it can't be argued they're good for these companies' bottom lines.

So why are Medibank and NIB in the buy zone then?

Well, firstly the share prices of Medibank and NIB have taken a hit today. Medibank reported its half-year earnings this morning and it wasn't a pretty picture. Earnings per share were down 14.3%. The company kept its dividend steady but is now paying out 88% of earnings to cover it – up from 67% last year. That's not a good sign. In response, the Medibank share price is under $3 at the time of writing – down 1.85% to $2.92.

But here's why this might be a buying opportunity.

In my opinion, the government isn't going to let the private health insurance business model collapse. Private health takes a lot of pressure off the publicly-funded Medicare program. With our ageing population only going to get worse in the next decade or two, the government can't afford to take up the slack and would much rather the private sector do the heavy lifting.

So, I would expect some reforms coming down the road that will increase the viability of the current private health model – which in turn should increase the value of the businesses that run it.

This is just my opinion, but I don't see it going any other way.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Share Fallers

Why these top ASX shares sank 10%+ in April

It was a tough month for these popular shares.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today
Share Market News

Buy, hold, sell: Capricorn Metals, PLS Group, Fortescue shares

Bell Potter has reviewed its ratings and 12-month price targets on three ASX 200 mining shares.

Read more »

A group of young people celebrate and party outside.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors finally caught a break this Friday.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A panel of formidable business people stand in a group with serious looks on their faces as if in judgement of what's before them.
Broker Notes

3 ASX shares to buy: experts

In new notes, brokers say these ASX stocks are good buys today.

Read more »

Woman in red hat with scarf rejoicing in the city park with leaves falling.
Share Market News

Here's what happened to Wesfarmers shares in April

Wesfarmers had a rather strange April...

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Bell Potter is tipping a 40% return from this ASX 200 share

A 40% return could be on the cards for buyers of this share.

Read more »